Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Corcept Therapeutics Inc

NASDAQ: CORT · Life Sciences · 13 alerts · CIK 1088856

Share price
$69.22Close, Nov 16
Market cap
$7.58B
Shares outstanding
109.44MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Corcept Therapeutics Inc filings on SEC EDGAR ↗

4:31 PM ET Form 4
Insider Selling

Corcept Therapeutics Director Daniel N. Swisher Jr. Sells $111K of Stock

Daniel N. Swisher Jr., Director, sold 1,500 shares of Corcept Therapeutics Inc at $74.07 a share, worth $111K in total on Nov 10, 2026. Shares held after the trade: 0 (-100.0%).

Value
$111K
Shares
1,500
Price
$74.07
Role
Director
Holding change
-100.0%
Trade date
Nov 10, 2026
7:27 PM ET Form 4
Insider Selling

Corcept Therapeutics Insider Sean Maduck Sells $2.05M of Stock

Sean Maduck sold 25,000 shares of Corcept Therapeutics Inc at $81.42 to $82.68 a share (average $81.85) in 3 transactions, worth $2.05M in total between Nov 2, 2026 and Nov 3, 2026. Shares held after the trade: 9,938 (-31.4%).

Value
$2.05M
Shares
25,000
Average price
$81.85
Holding change
-31.4%
Trade date
Nov 2, 2026 to Nov 3, 2026
7:21 PM ET Form 4
Insider Selling

Corcept Therapeutics President, Oncology Roberto Wandenkolk Vieira Sells $674K of Stock

Roberto Wandenkolk Vieira, President, Oncology, sold 8,333 shares of Corcept Therapeutics Inc at $80.73 to $81.52 a share (average $80.89) in 2 transactions, worth $674K in total on Nov 2, 2026. Shares held after the trade: 3,946 (-29.8%).

Value
$674K
Shares
8,333
Average price
$80.89
Role
President, Oncology
Holding change
-29.8%
Trade date
Nov 2, 2026
6:26 PM ET Form 4
Insider Selling

Corcept Therapeutics Director James N. Wilson Sells $1.15M of Stock

James N. Wilson, Director, sold 10,000 shares of Corcept Therapeutics Inc at $114.48 to $116.30 a share (average $114.81) in 3 transactions, worth $1.15M in total on Oct 15, 2026. Shares held after the trade: 1,054,543 (-0.0%).

Value
$1.15M
Shares
10,000
Average price
$114.81
Role
Director
Holding change
-0.0%
Trade date
Oct 15, 2026
7:59 PM ET Form 4
Insider Selling

Corcept Therapeutics President, Oncology Roberto Wandenkolk Vieira Sells $967K of Stock

Roberto Wandenkolk Vieira, President, Oncology, sold 8,333 shares of Corcept Therapeutics Inc at $114.52 to $116.58 a share (average $116.10) in 3 transactions, worth $967K in total on Oct 2, 2026. Shares held after the trade: 3,946 (-56.6%).

Value
$967K
Shares
8,333
Average price
$116.10
Role
President, Oncology
Holding change
-56.6%
Trade date
Oct 2, 2026
7:54 PM ET Form 4
Insider Selling

Corcept Therapeutics Insider Joseph Douglas Lyon Sells $1.16M of Stock

Joseph Douglas Lyon sold 10,000 shares of Corcept Therapeutics Inc at $115.40 to $116.54 a share (average $116.07) in 3 transactions, worth $1.16M in total between Oct 1, 2026 and Oct 2, 2026. Shares held after the trade: 5,683 (-45.5%).

Value
$1.16M
Shares
10,000
Average price
$116.07
Holding change
-45.5%
Trade date
Oct 1, 2026 to Oct 2, 2026
7:49 PM ET Form 4
Insider Selling

Corcept Therapeutics Insider Sean Maduck Sells $2.91M of Stock

Sean Maduck sold 25,000 shares of Corcept Therapeutics Inc at $115.54 to $116.55 a share (average $116.26) in 3 transactions, worth $2.91M in total between Oct 1, 2026 and Oct 2, 2026. Shares held after the trade: 9,938 (-46.8%).

Value
$2.91M
Shares
25,000
Average price
$116.26
Holding change
-46.8%
Trade date
Oct 1, 2026 to Oct 2, 2026
7:53 PM ET Form 4
Insider Selling

Corcept Therapeutics President, Oncology Roberto Wandenkolk Vieira Sells $29.8K of Stock

Roberto Wandenkolk Vieira, President, Oncology, sold 296 shares of Corcept Therapeutics Inc at $100.82 a share, worth $29.8K in total on Sep 16, 2026. Shares held after the trade: 3,946 (-7.0%).

Value
$29.8K
Shares
296
Price
$100.82
Role
President, Oncology
Holding change
-7.0%
Trade date
Sep 16, 2026
4:31 PM ET Form 4
Insider Selling

Corcept Therapeutics Insider Joseph Douglas Lyon Sells $1.13M of Stock

Joseph Douglas Lyon sold 10,000 shares of Corcept Therapeutics Inc at $113.32 to $114.12 a share (average $113.49) in 2 transactions, worth $1.13M in total on Sep 14, 2026. Shares held after the trade: 5,683 (-27.8%).

Value
$1.13M
Shares
10,000
Average price
$113.49
Holding change
-27.8%
Trade date
Sep 14, 2026
4:30 PM ET Form 4
Insider Selling

Corcept Therapeutics Director James N. Wilson Sells $1.11M of Stock

James N. Wilson, Director, sold 10,000 shares of Corcept Therapeutics Inc at $110.27 to $111.70 a share (average $110.69) in 3 transactions, worth $1.11M in total on Sep 15, 2026. Shares held after the trade: 1,064,543 (-0.3%).

Value
$1.11M
Shares
10,000
Average price
$110.69
Role
Director
Holding change
-0.3%
Trade date
Sep 15, 2026

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.